Evaluation of Current Regulation and Guidelines of Pharmacogenomic Drug Labels: Opportunities for Improvements

Pharmacogenomic drug labels in the Summary of Product Characteristics (SmPC) provide an instrument for clinical implementation of pharmacogenomics. We compared pharmacogenomic guidance by Clinical Pharmacogenetics Implementation Consortium (CPIC), Dutch Pharmacogenetics Working Group (DPWG), the US...

Descripción completa

Detalles Bibliográficos
Autores principales: Shekhani, Rawan, Steinacher, Linda, Swen, Jesse J., Ingelman‐Sundberg, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232863/
https://www.ncbi.nlm.nih.gov/pubmed/31715018
http://dx.doi.org/10.1002/cpt.1720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232863/
https://www.ncbi.nlm.nih.gov/pubmed/31715018
http://dx.doi.org/10.1002/cpt.1720

Ejemplares similares